Zelluna announces collaboration with Etcembly for AI-enabled TCR engineering
· zelluna asa
AI Briefing
- Zelluna and Etcembly collaborate on AI-enabled TCR engineering for cancer treatment.
- The partnership aims to accelerate the development of allogeneic TCR-NK cell therapies.
- The collaboration brings together Zelluna's expertise in TCR engineering with Etcembly's machine learning capabilities.
Advertisement